February 29, 2016 — Fujifilm Medical Systems U.S.A. Inc. announced it has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for the sale and distribution of its most recent picture archiving and communication system (PACS) technology, Synapse 5. The system is the latest offering of Fujifilm’s comprehensive Synapse line of solutions that also includes vendor-neutral archive (VNA), 3-D, radiology information system (RIS), cardiovascular and mobile offerings.
Synapse 5 will be on display at the Healthcare Informatics and Management Systems Society (HIMSS) 2016 conference and exhibition, held Feb. 29 - March 4 in Las Vegas.
Fujifilm's base of current PACS customers will be able to take advantage of the speed of Synapse 5 through an upgrade to their current system. It will deliver a server-side, zero-download viewer utilizing a browser-independent desktop experience. Synapse 5 stands to save organizations significant resources due to less desktop management and a dramatic reduction in bandwidth requirements, which many are currently consuming today with last-generation PACS technology.
Synapse 5 was introduced at the 2015 scientific assembly and annual meeting of the Radiological Society of North America (RSNA), Nov. 29-Dec. 3 in Chicago. The platform will be available for commercial release in the U.S. market in the second half of 2016.
For more information: www.fujfilmusa.com
July 16, 2026 
